News

Displaying 1 - 20 of 27

International Overdose Awareness Day: EMCDDA answers key questions on drug-related deaths

How many people die every year in Europe from a drug-related death? Are women and men affected equally? What substances are involved in these fatalities? These are some of the questions answered...

25 years of monitoring and responding to new drugs in Europe — update published today

This year, the EU Early Warning System (EWS) on new psychoactive substances (NPS) celebrates its 25th anniversary. Operated by the EMCDDA, in close cooperation with Europol and partners (1), it was the...

Emergency vehicle driving fast on a blurred street

New EMCDDA miniguide on responding to opioid-related deaths highlights approaches and evidence that can help save lives

Health and social responses to opioid-related deaths are explored in a new EMCDDA miniguide launched today. The resource is the ninth in a series of miniguides, making up the agency’s latest overview...

EMCDDA releases new European miniguides on responding to drug problems

What are the most effective treatment options for cannabis problems? How to respond to new trends in cocaine use? How to help prevent the non-medical use of medicines? These are among the...

hepatitis world day theme 2021: hep can't wait

EMCDDA launches new resources to help European countries beat viral hepatitis

On World Hepatitis Day, the EU drugs agency (EMCDDA) is launching a new set of resources to help European countries meet health targets to eliminate viral hepatitis. The resources, presented in an...

image of part of the european drug report 2021

European drug market proves resilient to COVID-19 disruption

Today, the EU drugs agency (EMCDDA) publishes its European Drug Report 2021: Trends and Developments, the latest annual review of the drug situation in Europe (1). Based on data from 29 countries...

yellow and white pills on a light grey background

New report highlights public health risks and increasing availability of ‘designer benzodiazepines’ in Europe

New benzodiazepines, which are not controlled by international drug laws, come under the spotlight today in a new report released by the EU drugs agency (EMCDDA) (1). Often marketed as ‘designer benzodiazepines’...

image of covid19 virus

EMCDDA releases third trendspotter study on COVID-19 and drugs

In the third in its series of rapid ‘trendspotter’ studies, the EMCDDA explores the impact of COVID-19 on the drug situation and responses to it. Revisiting and reviewing findings from two studies...

Euro-DEN Plus network prepares to expand beyond the EU

Data from hospital emergency departments show that every year in Europe thousands of individuals experience drug-related toxicity and other harms, resulting in emergency presentations to hospital (1). Supported by the EMCDDA, the...

map highlighting EU4MD partner countries

EMCDDA releases study findings on the impact of COVID-19 on drug markets, use and services in the southern ENP region

The emergence of new drug trafficking routes, the reduced availability of drug-related health services and the adaptation of drug treatment protocols during the COVID-19 pandemic are among the findings highlighted today in...

EMCDDA releases study findings on the impact of COVID-19 on drug markets, use and services in the eastern ENP region

The expansion of contactless drug dealing, the increase in the use of licit drugs and the adaptation of drug treatment protocols during lockdown are among the findings highlighted today in a new...

EDR covers

COVID-19 disruption and a strong drug market bring new threats to health and security in Europe

High availability across all drug types, drug production within Europe and highly potent substances are among the concerns addressed today by the EU drugs agency (EMCDDA) in its European Drug Report 2020...

Computer-generated simulation of a corona virus (copyrighted)

COVID-19: New EMCDDA study highlights decline in stimulant drug use but some rises in the use of cannabis, alcohol and prescription medicines to combat anxiety and depression

A decline in stimulant drug use but some rises in the consumption of cannabis and licit substances are among the findings presented today in a new EMCDDA report The impact of COVID-19...

Drug overdoses can be prevented — new resources released

Latest estimates show that drug overdose deaths in Europe have risen for the fifth consecutive year, with a record 9 461 lives lost in 2017 (EU 28, Turkey and Norway). Reducing drug-related...

Latest update on drug-related infectious diseases in Europe

The EMCDDA has published today its latest update on Drug-related infectious diseases in Europe for the period to February 2019. The publication provides an overview of the most recent infectious disease surveillance...

Prison cell

Preventing blood-borne viruses in prison settings: ECDC and EMCDDA guidance

People in prison experience a higher burden of communicable diseases such as hepatitis B (HBV), hepatitis C (HCV) and HIV often linked to a history of injecting drug use. In addition, incarceration...

EMCDDA–ECDC cooperation: building a healthier Europe

EMCDDA Director Alexis Goosdeel is paying an official visit to the European Centre for Disease Prevention and Control (ECDC) in Stockholm today where he will spend two days discussing opportunities for further...

#WorldHepatitisDay: EMCDDA joins forces with partners to address viral hepatitis elimination targets

Every year, on 28 July, the World Health Organization (WHO) and partners mark World Hepatitis Day (WHD) to increase awareness and understanding of viral hepatitis and the diseases it causes. Read news...

Virus

EMCDDA and ECDC join forces to address the challenge of hepatitis

Hepatitis and other drug-related infectious diseases will be the focus of ‘Hepatitis week’, taking place at the EMCDDA in Lisbon from 12–16 June. The initiative brings together some 100 specialists in the...

Close-up of virus

New EMCDDA report shows grounds for hope in treating hepatitis C

Hepatitis C is an infectious disease of the liver caused by the blood-borne hepatitis C virus. In a new report published today on World Hepatitis Day, the EU drugs agency (EMCDDA) looks...